Infections (predominantly upper respiratory tract infections and urinary tract infections), blood immunoglobulin decrease (IgG, IgA, and IgM), and diarrhea are the most common treatment-emergent adverse events (8, 10). Here, CD79A is linked to Recurrent upper respiratory tract infections.